1. An intracellular pathway is required for ABA-tyrosine presentation to T cells.
- Author
-
Joshi N, Baskar S, and Leskowitz S
- Subjects
- Animals, Cell Line, Chloroquine pharmacology, Formaldehyde pharmacology, Histocompatibility Antigens Class II metabolism, Lysosomes metabolism, Mice, Tyrosine metabolism, p-Azobenzenearsonate analogs & derivatives, Antigen-Presenting Cells metabolism, Azo Compounds metabolism, T-Lymphocytes immunology, Tyrosine analogs & derivatives, p-Azobenzenearsonate metabolism
- Abstract
Although tyrosine-azobenzenearsonate (ABA-Tyr) is not degraded by proteolytic enzymes, its presentation by accessory cells is inhibited by lysosomotropic agents such as chloroquine. Presentation of ABA-poly-L-glutamic, alanine, tyrosine (ABA-GAT) is similarly inhibited by chloroquine, but in contrast to ABA-Tyr it is also inhibited by leupeptin. Finally formaldehyde fixation of accessory cells after pulsing with ABA-Tyr but not before permits successful stimulation of ABA-specific hybridoma cells. These results suggest that a lysosomal pathway but not digestion is necessary for the association of ABA-Tyr and la molecules for presentation.
- Published
- 1990
- Full Text
- View/download PDF